Ganga Pharmaceuticals (GANGAPHARM) Shareholding Pattern

NSE: GANGAPHARM • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 50.91%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 35.32%
Total Shareholders 366
As of Sept 2025
View the latest shareholding pattern of Ganga Pharmaceuticals (GANGAPHARM) including promoter, FII, DII, and public holdings. Track GANGAPHARM ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See GANGAPHARM 52-week high low)

Ganga Pharmaceuticals (GANGAPHARM) Shareholding Summary

  • Promoter holding remains unchanged at 50.91% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has decreased from 35.46% to 35.32% in Sept 2025
  • Number of shareholders decreased from 367 to 366 in Sept 2025

GANGAPHARM Quarterly Ownership Changes

Quarter-over-quarter changes for Ganga Pharmaceuticals from Jul 2025 to Sept 2025.

Promoter Holding Change
Jul 2025 to Sept 2025
No Change
FII Holding Change
Jul 2025 to Sept 2025
No Change
DII Holding Change
Jul 2025 to Sept 2025
No Change
Public Holding Change
Jul 2025 to Sept 2025
-0.14%

Ganga Pharmaceuticals (GANGAPHARM) Quarterly Shareholding Trends

Visual breakdown of GANGAPHARM ownership distribution over time. Learn more about GANGAPHARM price movement history.

Promoter
FII
DII
Public
Government

Rising institutional holdings in GANGAPHARM often correlate with improved fundamentals. Check out GANGAPHARM dividend growth.

Ganga Pharmaceuticals (GANGAPHARM) Shareholding Data

Download complete GANGAPHARM ownership data for offline analysis. Discover GANGAPHARM book value.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 50.91% 0.00% 0.00% 0.00% 35.32% 13.77% 100.00% 366
Jul 2025 50.91% 0.00% 0.00% 0.00% 35.46% 13.63% 100.00% 367
Jun 2025 50.91% 0.00% 0.00% 0.00% 35.46% 13.63% 100.00% 367
Mar 2025 56.02% 0.00% 0.00% 0.00% 35.07% 8.91% 100.00% 368
Sept 2024 56.02% 0.00% 0.00% 0.00% 35.23% 8.75% 100.00% 365
Mar 2024 56.02% 0.00% 0.00% 0.00% 35.40% 8.58% 100.00% 363
Dec 2023 56.02% 0.00% 0.00% 0.00% 35.23% 8.75% 100.00% 362
Sept 2023 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 359
Mar 2023 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 356
Sept 2022 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 355
Jun 2022 66.71% 0.00% 0.00% 0.00% 32.30% 0.98% 99.99% 356
Mar 2022 66.71% 0.00% 0.00% 0.00% 32.50% 0.79% 100.00% 356
Dec 2021 66.71% 0.00% 0.00% 0.00% 32.30% 0.98% 99.99% 354
Sept 2021 66.71% 0.00% 0.00% 0.00% 32.30% 0.98% 99.99% 354
Jun 2021 66.71% 0.00% 0.00% 0.00% 32.11% 1.18% 100.00% 354
Mar 2021 66.71% 0.00% 0.00% 0.00% 32.11% 1.18% 100.00% 354

GANGAPHARM promoter holding above 50% indicates strong insider confidence. Explore the GANGAPHARM market cap trends for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 50.91% 0.00% 0.00% 0.00% 35.32% 13.77% 100.00% 366
Jul 2025 50.91% 0.00% 0.00% 0.00% 35.46% 13.63% 100.00% 367
Jun 2025 50.91% 0.00% 0.00% 0.00% 35.46% 13.63% 100.00% 367
Mar 2025 56.02% 0.00% 0.00% 0.00% 35.07% 8.91% 100.00% 368
Sept 2024 56.02% 0.00% 0.00% 0.00% 35.23% 8.75% 100.00% 365
Mar 2024 56.02% 0.00% 0.00% 0.00% 35.40% 8.58% 100.00% 363
Dec 2023 56.02% 0.00% 0.00% 0.00% 35.23% 8.75% 100.00% 362
Sept 2023 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 359
Mar 2023 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 356
Sept 2022 66.71% 0.00% 0.00% 0.00% 31.91% 1.38% 100.00% 355
Jun 2022 66.71% 0.00% 0.00% 0.00% 32.30% 0.98% 99.99% 356
Mar 2022 66.71% 0.00% 0.00% 0.00% 32.50% 0.79% 100.00% 356

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 56.02% 0.00% 0.00% 0.00% 35.07% 8.91% 100.00% 368
Mar 2024 56.02% 0.00% 0.00% 0.00% 35.40% 8.58% 100.00% 363
Dec 2023 56.02% 0.00% 0.00% 0.00% 35.23% 8.75% 100.00% 362
Mar 2022 66.71% 0.00% 0.00% 0.00% 32.50% 0.79% 100.00% 356
Dec 2021 66.71% 0.00% 0.00% 0.00% 32.30% 0.98% 99.99% 354

Year-over-year trends reveal long-term ownership shifts.

Understanding Ganga Pharmaceuticals (GANGAPHARM) Shareholding Pattern

Ganga Pharmaceuticals shareholding pattern reveals who owns GANGAPHARM stock and how ownership changes over time. High promoter stakes in GANGAPHARM often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your GANGAPHARM trades. Ganga Pharmaceuticals intrinsic worth

Combine GANGAPHARM ownership analysis with price movements and financial performance for a complete investment picture. (See GANGAPHARM DCF)